TIRZEPATIDE for Hyperinsulinaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where TIRZEPATIDE was used for Hyperinsulinaemia.
Most Reported Side Effects for TIRZEPATIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Incorrect dose administered | 23,301 | 23.3% | 1 | 67 |
| Injection site pain | 10,989 | 11.0% | 0 | 33 |
| Nausea | 10,018 | 10.0% | 20 | 867 |
| Off label use | 7,007 | 7.0% | 21 | 425 |
| Extra dose administered | 6,774 | 6.8% | 1 | 32 |
| Diarrhoea | 5,463 | 5.5% | 22 | 725 |
| Vomiting | 4,635 | 4.6% | 27 | 1,004 |
| Injection site haemorrhage | 4,389 | 4.4% | 0 | 12 |
| Accidental underdose | 3,897 | 3.9% | 0 | 7 |
| Injection site erythema | 3,844 | 3.9% | 0 | 14 |
| Constipation | 3,417 | 3.4% | 6 | 341 |
| Product dose omission issue | 3,211 | 3.2% | 0 | 47 |
| Injection site bruising | 2,665 | 2.7% | 0 | 14 |
| Drug ineffective | 2,648 | 2.7% | 0 | 44 |
| Fatigue | 2,301 | 2.3% | 5 | 123 |
Other Indications for TIRZEPATIDE
Product used for unknown indication (56,075)
Weight control (17,354)
Type 2 diabetes mellitus (14,571)
Diabetes mellitus (5,209)
Weight decreased (2,625)
Glucose tolerance impaired (2,452)
Obesity (700)
Sleep apnoea syndrome (654)
Insulin resistance (572)
Glycosylated haemoglobin increased (564)